GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » Accounts Receivable

Schott Pharma AG KGaA (CHIX:1SXPD) Accounts Receivable : €151.4 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Schott Pharma AG KGaA Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Schott Pharma AG KGaA's accounts receivables for the quarter that ended in Dec. 2024 was €151.4 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Schott Pharma AG KGaA's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 60.12.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Schott Pharma AG KGaA's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was €-2.90.


Schott Pharma AG KGaA Accounts Receivable Historical Data

The historical data trend for Schott Pharma AG KGaA's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Accounts Receivable Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Accounts Receivable
99.52 117.62 146.43 165.49 174.89

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 148.08 169.97 181.95 174.89 151.43

Schott Pharma AG KGaA Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Schott Pharma AG KGaA Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Schott Pharma AG KGaA's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=151.43/229.841*91
=60.12

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Schott Pharma AG KGaA's accounts receivable are only considered to be worth 75% of book value:

Schott Pharma AG KGaA's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(23.727+0.75 * 151.43+0.5 * 152.387-648.054
-0-1.989)/150.615
=-2.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Schott Pharma AG KGaA Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines